Matches in Nanopublications for { ?s ?p "[Treatment of CD40 or BCR activated CLL cells with PCI-32765 results in inhibition of BTK tyrosine phosphorylation and also effectively abrogates downstream survival pathways activated by this kinase including ERK1/2, PI3K, and NF-?B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- assertion description "[Treatment of CD40 or BCR activated CLL cells with PCI-32765 results in inhibition of BTK tyrosine phosphorylation and also effectively abrogates downstream survival pathways activated by this kinase including ERK1/2, PI3K, and NF-?B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP294554.RAw_9RDw8PoXYrGTyfdS6CNnRwUObUlrVekKPWGJRfKj8130_assertion description "[Treatment of CD40 or BCR activated CLL cells with PCI-32765 results in inhibition of BTK tyrosine phosphorylation and also effectively abrogates downstream survival pathways activated by this kinase including ERK1/2, PI3K, and NF-?B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP294554.RAw_9RDw8PoXYrGTyfdS6CNnRwUObUlrVekKPWGJRfKj8130_provenance.
- NP881039.RAMOQLSsBAH_bwrpwR5_VRr-L6ohnNFcBqEwRnMd4VC7I130_assertion description "[Treatment of CD40 or BCR activated CLL cells with PCI-32765 results in inhibition of BTK tyrosine phosphorylation and also effectively abrogates downstream survival pathways activated by this kinase including ERK1/2, PI3K, and NF-?B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP881039.RAMOQLSsBAH_bwrpwR5_VRr-L6ohnNFcBqEwRnMd4VC7I130_provenance.